Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.39B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 3 |
Citigroup
C
|
+$429M |
| 4 |
United States Oil Fund
USO
|
+$386M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$378M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$946M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$771M |
| 3 |
Alibaba
BABA
|
+$626M |
| 4 |
Tesla
TSLA
|
+$505M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$421M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.01% |
| 2 | Communication Services | 1.39% |
| 3 | Financials | 0.98% |
| 4 | Consumer Discretionary | 0.94% |
| 5 | Healthcare | 0.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
CALL
Moody's
MCO
$88.2B
| $15.5M | ﹤0.01% |
73,300
+32,200
| +78% | +$7.83M |
|
|
RESI
1352
CALL
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $15.5M | ﹤0.01% |
1,296,100
+9,000
| +0.7% | +$105K |
|
|
AXON
1353
CALL
Axon Enterprise
AXON
$49.4B
| $15.5M | ﹤0.01% |
218,400
+700
| +0.3% | +$52.4K |
|
1354
PUT
iShares MSCI United Kingdom ETF
EWU
$3.86B
| $15.4M | ﹤0.01% |
646,600
+323,900
| +100% | +$9.69M |
|
1355
CALL
Insulet
PODD
$9.93B
| $15.3M | ﹤0.01% |
92,300
+46,300
| +101% | +$8.46M |
|
1356
KKR & Co
KKR
$96.1B
| $15.3M | ﹤0.01% |
651,458
-57,456
| -8% | -$1.65M |
|
|
FISV
1357
PUT
Fiserv Inc
FISV
$27.9B
| $15.3M | ﹤0.01% |
160,800
+5,300
| +3% | +$589K |
|
1358
KraneShares CSI China Internet ETF
KWEB
$5.21B
| $15.3M | ﹤0.01% |
337,355
+169,076
| +100% | +$8.33M |
|
1359
PUT
Cleveland-Cliffs
CLF
$6.5B
| $15.3M | ﹤0.01% |
3,861,300
+1,127,100
| +41% | +$7.09M |
|
|
LKFT
1360
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $15.2M | ﹤0.01% |
77,800
-16,400
| -17% | -$3.53M |
|
1361
PUT
iShares MSCI Germany ETF
EWG
$1.74B
| $15.2M | ﹤0.01% |
708,700
+99,600
| +16% | +$2.65M |
|
1362
PUT
Canadian Pacific Kansas City
CP
$83.8B
| $15.2M | ﹤0.01% |
345,500
+216,500
| +168% | +$10.7M |
|
|
RDS.A
1363
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $15.2M | ﹤0.01% |
434,250
+338,046
| +351% | +$15.8M |
|
1364
PUT
iShares US Healthcare Providers ETF
IHF
$1.23B
| $15.1M | ﹤0.01% |
454,000
+325,000
| +252% | +$12.3M |
|
1365
CALL
Xcel Energy
XEL
$48.3B
| $15.1M | ﹤0.01% |
250,800
+63,500
| +34% | +$4.14M |
|
1366
CALL
iShares S&P 500 Growth ETF
IVW
$75.9B
| $15.1M | ﹤0.01% |
365,600
+42,000
| +13% | +$1.99M |
|
1367
Mondelez International
MDLZ
$81.5B
| $15.1M | ﹤0.01% |
300,732
-195,970
| -39% | -$10.6M |
|
1368
CALL
Tandem Diabetes Care
TNDM
$1.5B
| $15.1M | ﹤0.01% |
234,000
+60,500
| +35% | +$4.24M |
|
1369
CALL
Iovance Biotherapeutics
IOVA
$3.81B
| $15M | ﹤0.01% |
502,200
+132,500
| +36% | +$3.51M |
|
1370
PUT
Axsome Therapeutics
AXSM
$10.8B
| $15M | ﹤0.01% |
255,500
-214,300
| -46% | -$17.5M |
|
1371
PUT
iShares MSCI Canada ETF
EWC
$6.93B
| $15M | ﹤0.01% |
687,500
+574,000
| +506% | +$15.7M |
|
1372
Invitation Homes
INVH
$17.9B
| $15M | ﹤0.01% |
702,521
+355,663
| +103% | +$10.1M |
|
1373
CALL
Weibo
WB
$1.74B
| $15M | ﹤0.01% |
452,700
-321,000
| -41% | -$13.6M |
|
1374
PUT
Quest Diagnostics
DGX
$26.9B
| $15M | ﹤0.01% |
186,400
+142,100
| +321% | +$14.7M |
|
1375
CALL
Guardant Health
GH
$22.3B
| $15M | ﹤0.01% |
215,000
+116,700
| +119% | +$8.96M |
|
Similar funds
Jeff Yass's Q1 2020 Portfolio in Review
As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass deployed $31.5B of net new capital in Q1 2020, opening 1,843 new positions and adding to 4,539 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.2% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Amazon, an estimated $946M trimmed.
- Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
- Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
- Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
- Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
- Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
- Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.